Understanding PGD (Preimplantation Genetic Diagnosis)
Preimplantation Genetic Diagnosis (PGD), often referred to as embryo biopsy, is a sophisticated reproductive technology used in conjunction with In Vitro Fertilization (IVF). This procedure allows fertility specialists to screen embryos for specific genetic diseases or chromosomal abnormalities before they are transferred to the uterus. In Istanbul, Turkey, our clinics utilize the latest genetic screening technologies to assist couples in building healthy families.
Initially introduced over 16 years ago, PGD has been performed in tens of thousands of cycles globally. Its primary function is the selection and transfer of euploid embryos (embryos with the correct number of chromosomes), significantly improving the likelihood of a successful pregnancy for many patients. Whether you are opting for a blastocyst embryo transfer or a Day 3 transfer, PGD provides an extra layer of diagnostic security.
The PGD Procedure: Step-by-Step
The PGD process is integrated into the IVF cycle. While the traditional method involved biopsy on Day 3, modern advancements often allow for biopsies at the blastocyst stage (Day 5 or 6). Here is how the process typically unfolds:
Embryo Culture and Biopsy
Three days after the Intracytoplasmic Sperm Injection (ICSI) procedure, when the embryos reach the 8-cell stage, a single cell (blastomere) may be removed. Alternatively, in many modern cases, a few cells are taken from the trophectoderm (the part that becomes the placenta) during the blastocyst stage. This biopsy is performed with extreme precision using specialized lasers to ensure the integrity of the embryo.
Genetic Analysis
The removed cells are sent to a specialized pathology and genetics laboratory. Here, they are analyzed for specific conditions that may be present due to family history, maternal age, or known genetic predispositions. This analysis is crucial for avoiding the birth of children with inherited diseases and eliminates the difficult decision of pregnancy termination later on.
Strategic Embryo Transfer
Once the results are returned, fertility experts select the healthiest embryos for the embryo transfer. To maximize the chances of successful implantation, doctors carefully place the selected embryos back into the uterus, typically landing them precisely within the uterine cavity where the lining is most receptive.
Key Benefits of PGD in IVF
PGD is not a requirement for every IVF patient, but it offers substantial benefits for those with specific risk factors:
- Improved Pregnancy Rates: By selecting only genetically healthy embryos, PGD improves implantation and pregnancy rates, particularly in poor-prognosis IVF cases.
- Reduced Miscarriage Risk: This technique has been shown to reduce spontaneous abortion rates by over four-fold in carriers of chromosomal translocations.
- Screening for Late-Onset Disorders: PGD applications are expanding to test for late-onset disorders, providing parents with information about the long-term health of the embryo.
- HLA Matching: In rare medical cases, PGD is used to produce HLA-matched offspring who can serve as potential stem cell donors for siblings with life-threatening illnesses.
- Scientific Research: PGD provides access to human embryonic stem cell lines, which are vital for researching primary disease mechanisms and developing new treatments for genetic disorders.
Who Should Consider Embryo Biopsy?
Success in IVF depends on various individual factors, including maternal age, egg quality, and genetic history. PGD is frequently recommended for:
- Women over the age of 35 (due to higher risks of chromosomal abnormalities).
- Couples who are known carriers of single-gene disorders (such as Cystic Fibrosis or Tay-Sachs).
- Patients with a history of recurrent miscarriages.
- Couples with repeated IVF failures despite high-quality embryo appearances.
Advanced Monitoring and PGD
At our centers in Istanbul, we often combine PGD with advanced monitoring techniques. For example, using an Embryoscope allows embryologists to monitor the development of embryos in real-time without removing them from the incubator, ensuring they are at the optimal stage for biopsy and transfer.
PGD (Embryo Biopsy) FAQ
Is the biopsy harmful to the embryo?
When performed by experienced embryologists using modern laser techniques, the risk of damaging the embryo is very low. Medical data suggests that the biopsy does not adversely affect the development of the fetus or the health of the child after birth, though no procedure is entirely without risk.
How long does it take to get PGD results?
The timeline depends on the specific genetic tests being performed. Some results are available within 24-48 hours, allowing for a fresh transfer, while more complex screenings may require the embryos to be frozen while the genetic lab completes the analysis.
Can PGD guarantee a 100% healthy baby?
While PGD is highly accurate (often 98% or higher) at detecting the specific conditions it is testing for, it cannot guarantee a 100% success rate or screen for every possible medical condition. It is a tool to significantly increase the probability of a healthy pregnancy based on individual genetic factors.